Kodiak Sciences Inc Phase 2b/3 Study in wet AMD Top-Line Results Transcript

Feb 23, 2022 / 01:00PM GMT
Operator

Good afternoon, and welcome to the Kodiak Sciences Phase IIb/III study in wet AMD top line results call. My name is Marion, and I will facilitate the audio portion of today's interactive broadcast. (Operator Instructions) Today's conference is being recorded.

At this time, I would like to turn the conference over to John Borgeson, CFO of Kodiak. Please go ahead.

John A. Borgeson - Kodiak Sciences Inc. - Senior VP, CFO & Secretary

Thank you for joining Kodiak Sciences' conference call. I'm John Borgeson, Kodiak's Chief Financial Officer. Joining me today are Victor Perlroth, Chairman and CEO; and Jason Ehrlich, Chief Medical Officer and Chief Development Officer. After our prepared remarks, we will open the call for Q&A.

The webcast portion of this call contains a slide presentation that we will refer to during the call. Those following along on the phone who wish to access the slide portion of this presentation may do so on the Investor Relations section of our website. An archive of this webcast will be available on our website.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot